Urinary metabolites of a novel quinoxaline non-nucleoside reverse transcriptase inhibitor in dog, cynomolgus monkey and mini-pig

By Ismail I. M.   Dear G. J.   Mutch P. J.   Davies L. H.   Plumb R. S.   Sweatman B. C.  

Xenobiotica, Vol. 29, Iss. 9, 1999-09 ,pp. : 957-967

Informa Healthcare

Access to resources Recommend Favorite

Conformation depends on 4D-QSAR analysis using EC-GA method: pharmacophore identification and bioactivity prediction of TIBOs as non-nucleoside reverse transcriptase inhibitors

By Akyüz Lalehan   Sarıpınar Emin  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 28, Iss. 4, 2013-08 ,pp. : 776-791

Informa Healthcare

Access to resources Recommend Favorite

The disposition and metabolism of GW695634: A non-nucleoside reverse transcriptase inhibitor (NNRTi) for treatment of HIV/AIDS

By de Serres Mark   Moss Lee   Sigafoos James   Sefler Andrea   Castellino Stephen   Bowers Gary   Serabjit-Singh Cosette  

Xenobiotica, Vol. 40, Iss. 6, 2010-06 ,pp. : 437-445

Informa Healthcare

Access to resources Recommend Favorite

Pre-clinical pharmacokinetics of UK-453,061, a novel non-nucleoside reverse transcriptase inhibitor (NNRTI), and use of in silico physiologically based prediction tools to predict the oral pharmacokinetics of UK-453,061 in man

By Allan G.   Davis J.   Dickins M.   Gardner I.   Jenkins T.   Jones H.   Webster R.   Westgate H.  

Xenobiotica, Vol. 38, Iss. 6, 2008-06 ,pp. : 620-640

Informa Healthcare

Access to resources Recommend Favorite

Investigation of Novel Lipid-Functionalized PNA Monomers as Potential HIV-1 Non-Nucleoside Reverse Transcriptase and/or Integrase Inhibitors

By Thomas Michael   Maga Giovanni   Mouscadet Jean-François   Howarth Nicola  

Nucleosides, Nucleotides & Nucleic Acids, Vol. 26, Iss. 8-9, 2007-08 ,pp. : 1063-1066

Taylor & Francis Ltd

Access to resources Recommend Favorite